A police officer receiving the AstraZeneca (AZ) vaccine. [Image source=Yonhap News]

A police officer receiving the AstraZeneca (AZ) vaccine. [Image source=Yonhap News]

View original image


[Asia Economy Reporter Lee Gwan-joo] The police have formed a task force (TF) to support employees who experienced adverse reactions after receiving the COVID-19 vaccine and decided to assist with applications for national compensation.


According to the police on the 11th, Choi Jong-moon, Director of Police Personnel Planning (Chief Superintendent), posted on the police internal network the day before to announce this. Director Choi said, "Most completed the first dose without major issues, but unfortunately, some showed severe adverse reactions," adding, "We plan to form a TF to help stabilize and recover the affected individuals and their families."


He continued, "We will enable cost support through customized group insurance to prevent any inconvenience related to medical expenses during the national compensation process," and added, "We will also closely support the application procedures for official sick leave and leave of absence."


He further explained, "Even if national compensation is not recognized, we will provide support to prove the causal relationship between official duties and illness through consultations with specialized labor law firms," and "We are also reviewing additional support measures such as consolation payments using funds."


The first round of COVID-19 vaccinations for police officers was conducted from March 26 to April 8. Among 117,579 eligible individuals aged 30 and above, 84,324 were vaccinated, showing a vaccination rate of 71.7%.



However, during this process, internal complaints surged that the vaccination was conducted under coercion. An active-duty police officer even filed a complaint with the National Human Rights Commission regarding this matter.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing